1. Home
  2. BFS vs CRGX Comparison

BFS vs CRGX Comparison

Compare BFS & CRGX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • BFS
  • CRGX
  • Stock Information
  • Founded
  • BFS 1993
  • CRGX 2021
  • Country
  • BFS United States
  • CRGX United States
  • Employees
  • BFS N/A
  • CRGX N/A
  • Industry
  • BFS Real Estate Investment Trusts
  • CRGX
  • Sector
  • BFS Real Estate
  • CRGX
  • Exchange
  • BFS Nasdaq
  • CRGX Nasdaq
  • Market Cap
  • BFS 830.6M
  • CRGX 190.0M
  • IPO Year
  • BFS 1993
  • CRGX 2023
  • Fundamental
  • Price
  • BFS $35.13
  • CRGX $4.40
  • Analyst Decision
  • BFS Strong Buy
  • CRGX Hold
  • Analyst Count
  • BFS 1
  • CRGX 7
  • Target Price
  • BFS $45.50
  • CRGX $4.67
  • AVG Volume (30 Days)
  • BFS 66.5K
  • CRGX 527.8K
  • Earning Date
  • BFS 07-31-2025
  • CRGX 08-11-2025
  • Dividend Yield
  • BFS 6.71%
  • CRGX N/A
  • EPS Growth
  • BFS N/A
  • CRGX N/A
  • EPS
  • BFS 1.47
  • CRGX N/A
  • Revenue
  • BFS $274,011,000.00
  • CRGX N/A
  • Revenue This Year
  • BFS $7.78
  • CRGX $57.81
  • Revenue Next Year
  • BFS $6.78
  • CRGX N/A
  • P/E Ratio
  • BFS $23.61
  • CRGX N/A
  • Revenue Growth
  • BFS 5.04
  • CRGX N/A
  • 52 Week Low
  • BFS $31.25
  • CRGX $3.00
  • 52 Week High
  • BFS $42.39
  • CRGX $25.45
  • Technical
  • Relative Strength Index (RSI)
  • BFS 57.44
  • CRGX 55.41
  • Support Level
  • BFS $33.50
  • CRGX $4.09
  • Resistance Level
  • BFS $34.69
  • CRGX $4.31
  • Average True Range (ATR)
  • BFS 0.85
  • CRGX 0.19
  • MACD
  • BFS -0.02
  • CRGX -0.01
  • Stochastic Oscillator
  • BFS 83.16
  • CRGX 61.61

About BFS Saul Centers Inc.

Saul Centers Inc is a self-managed real estate investment trust which invests in, operates and develops retail and commercial properties. The company's portfolio includes community and neighbourhood shopping centres, office properties, and mixed-use properties. Properties are located in the Washington, D.C. and Batlimore metropolitan areas. Saul Centers operates through two business segments: shopping centers, which contribute the maximum portion of total revenue; and mixed-use properties. Maximum tenants include grocery stores, discount department stores, and drug stores.

About CRGX CARGO Therapeutics Inc.

Cargo Therapeutics Inc is a clinical-stage biotechnology company positioned to advance next generation, potentially curative cell therapies for cancer patients. It programs, platforms, and manufacturing are designed to directly address the limitations of approved chimeric antigen receptor (CAR) T-cell therapies. Its product includes CRG-023, an investigational tri-specific CAR T designed to address several known causes of relapse associated with existing CAR T-cell therapies such as loss of tumor antigen expression, loss of co-stimulation (e.g., via CD58/CD2 signaling) and T cell exhaustion. CRG-023 is designed to target the B-cell lineage antigens (CD19, CD20, CD22) via tri-cistronic expression of three distinct CARs from a single lentiviral vector.

Share on Social Networks: